<DOC>
	<DOCNO>NCT00446563</DOCNO>
	<brief_summary>This study evaluate safety efficacy amlodipine plus valsartan patient hypertension leave ventricular hypertrophy</brief_summary>
	<brief_title>Efficacy Safety Valsartan Combination With Amlodipine Compared Losartan Plus Hydrochlorothiazide Patients With Hypertension Left Ventricular Hypertrophy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Caucasian ; male female outpatient age 1880 year age , inclusive . Patients history essential hypertension actually treat either antihypertensive monotherapy diastolic blood pressure &gt; =90 &lt; = 105mmHg combination therapy ( limited two active compound ) diastolic blood pressure &gt; =90 &lt; = 100mmHg . Patients Left Ventricular Hypertrophy Severe hypertension Symptomatic heart failure History stroke , heart attack , coronary bypass surgery etc . Insulindependent diabetes mellitus poorly control diabetes mellitus . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Left ventricular hypertrophy , hypertension , valsartan , amlodipine</keyword>
</DOC>